TD Asset Management Inc

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1056053 Toronto, A6

Position in RYTM

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$4,305,521

+$932,999 QoQ

Shares Held

38,778

0.0% QoQ

Ownership

0.056%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#109

of 299 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. RYTM ranks #53 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	259,317	$161,694,522
2	VRTX	Vertex Pharmaceuticals Inc / Ma	207,960	$103,299,970
3	HALO	Halozyme Therapeutics, Inc.	1,115,730	$87,328,187
4	ALNY	Alnylam Pharmaceuticals, Inc.	233,696	$70,349,506
5	CYTK	Cytokinetics Inc	385,130	$32,809,224
6	RPRX	Royalty Pharma plc	567,497	$31,819,556
7	ASND	Ascendis Pharma A/S	119,085	$31,762,351
8	KYMR	Kymera Therapeutics, Inc.	272,900	$31,293,443

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,305,521	38,778	0.0%	Shares	Sole	2026-08-04
2026-03-31	$3,372,522	38,778	-29.6%	Shares	Sole	2026-05-11
2025-12-31	$5,892,552	55,050	-7.6%	Shares	Sole	2026-02-10
2025-09-30	$6,015,368	59,564	+6.4%	Shares	Sole	2025-11-10
2025-06-30	$3,538,640	56,000	+11.6%	Shares	Sole	2025-07-28
2025-03-31	$2,659,094	50,200	+5.0%	Shares	Sole	2025-05-07
2024-12-31	$2,675,844	47,800	+50.3%	Shares	Sole	2025-02-11
2024-09-30	$1,666,002	31,800	+2.6%	Shares	Sole	2024-11-01
2024-06-30	$1,272,860	31,000	+12.3%	Shares	Sole	2024-08-02
2024-03-31	$1,195,908	27,600	-27.0%	Shares	Sole	2024-05-08
2023-12-31	$1,737,666	37,800	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.